Crescent Biopharma (CBIO) Return on Capital Employed [ROCE] (2014 - 2026)
Crescent Biopharma (CBIO) posted Return on Capital Employed [ROCE] of -97.72% for Q2 2026, up 0.30 percentage points from -98.02% a year earlier but down 18.34 percentage points from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Crescent Biopharma's Return on Capital Employed [ROCE] came in at -149.81%, down 20.04 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has declined for seven consecutive years, with a five-year change of -113.78 percentage points (FY2020 to FY2025).
- In prior years, Crescent Biopharma's Return on Capital Employed [ROCE] was -129.78% in FY2024 (-35.65 pp), -94.12% in FY2023 (-20.28 pp), -73.84% in FY2022 (-14.41 pp) and -59.43% in FY2021 (-23.40 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of -311.01% in Q4 2024 to a high of -57.83% in Q3 2021 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last five quarters, with an average year-over-year change of +13.94 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2026, with a gain of 212.06 percentage points; the weakest was Q4 2024, with a drop of 218.43 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -79.38% (Q1 2026), -99.62% (Q4 2025) and -61.41% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Crescent Biopharma | 397.47 Mn | -309.83 Mn | - | -97.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97.72% |
| Mar 31, 2026 | -79.38% |
| Dec 31, 2025 | -99.62% |
| Sep 30, 2025 | -61.41% |
| Jun 30, 2025 | -98.02% |
| Mar 31, 2025 | -291.44% |
| Dec 31, 2024 | -311.01% |
| Sep 30, 2024 | -268.78% |
| Jun 30, 2024 | -163.80% |
| Mar 31, 2024 | -114.46% |
| Dec 31, 2023 | -92.58% |
| Sep 30, 2023 | -78.85% |
| Jun 30, 2023 | -66.77% |
| Mar 31, 2023 | -81.46% |
| Dec 31, 2022 | -105.33% |
| Sep 30, 2022 | -102.75% |
| Jun 30, 2022 | -97.60% |
| Mar 31, 2022 | -84.96% |
| Dec 31, 2021 | -71.03% |
| Sep 30, 2021 | -57.83% |
API Access
Crescent Biopharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();